We are live on ! Find out more
FMI

F/M Investments Portfolio holdings

AUM $1.97B
1-Year Est. Return 30.33%
This Fund
S&P 500
This Quarter Est. Return
-2.84%
1 Year Est. Return
+30.33%
3 Year Est. Return
+101.46%
5 Year Est. Return
+144.03%
10 Year Est. Return
–
AUM
$2.51B
AUM Growth
-$201M
Cap. Flow
-$78.6M
Cap. Flow %
-3.13%
Top 10 Hldgs %
32.12%
Holding
422
New
23
Increased
129
Reduced
193
Closed
31

Top Buys

Rank Stock Value
1
IDXX icon
Idexx Laboratories
IDXX
+$11.8M
2
C icon
Citigroup
C
+$6.42M
3
BLK icon
Blackrock
BLK
+$5.5M
4
HUBS icon
HubSpot
HUBS
+$4.88M
5
LRCX icon
Lam Research
LRCX
+$4.71M

Top Sells

Rank Stock Value
1
UNH icon
UnitedHealth
UNH
+$18.7M
2
ZTWO icon
F/M 2-Year Investment Grade Corporate Bond ETF
ZTWO
+$18.5M
3
AAPL icon
Apple
AAPL
+$10.2M
4
TFC icon
Truist Financial
TFC
+$9.55M
5
TBIL
F/m US Treasury 3 Month Bill Fund
TBIL
+$6.55M

Sector Composition

Rank Sector Weight
1 Technology 21.71%
2 Healthcare 11.09%
3 Financials 10.98%
4 Consumer Discretionary 8.01%
5 Industrials 7.96%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
EVR icon
226
Evercore
EVR
$11.8B
$2.05M 0.08%
10,244
-7,281
-42% -$1.81M
SPSC icon
227
SPS Commerce
SPSC
$2.64B
$2.02M 0.08%
15,245
-564
-4% -$88.7K
INSM icon
228
Insmed
INSM
$28.6B
$2M 0.08%
26,153
-16,640
-39% -$1.27M
CVS icon
229
CVS Health
CVS
$122B
$1.99M 0.08%
29,340
+798
+3% +$47.8K
MRSH
230
Marsh
MRSH
$91.5B
$1.98M 0.08%
+8,134
New +$1.85M
MDGL icon
231
Madrigal Pharmaceuticals
MDGL
$11.8B
$1.98M 0.08%
5,977
+3,718
+165% +$1.22M
BSX icon
232
Boston Scientific
BSX
$71.5B
$1.98M 0.08%
19,602
+16,144
+467% +$1.63M
OSPN icon
233
OneSpan
OSPN
$618M
$1.97M 0.08%
+129,151
New +$2.3M
WVE icon
234
Wave Life Sciences
WVE
$1.2B
$1.94M 0.08%
240,418
+14,384
+6% +$157K
IRM icon
235
Iron Mountain
IRM
$36.1B
$1.93M 0.08%
22,406
-1,031
-4% -$99.3K
LNT icon
236
Alliant Energy
LNT
$18B
$1.84M 0.07%
+28,652
New +$1.75M
OKE icon
237
Oneok
OKE
$54.5B
$1.8M 0.07%
18,168
– –
FDX icon
238
FedEx
FDX
$75.4B
$1.8M 0.07%
7,365
-301
-4% -$78K
FE icon
239
FirstEnergy
FE
$27.5B
$1.79M 0.07%
44,202
-1,891
-4% -$75.3K
TROW icon
240
T. Rowe Price
TROW
$24.3B
$1.78M 0.07%
19,405
-526
-3% -$55.6K
SPSM icon
241
State Street SPDR Portfolio S&P 600 Small Cap ETF
SPSM
$17.4B
$1.78M 0.07%
43,671
– –
GAP
242
The Gap Inc
GAP
$7.37B
$1.78M 0.07%
+86,183
New +$1.94M
BRK.B icon
243
Berkshire Hathaway Class B
BRK.B
$1.13T
$1.75M 0.07%
3,400
+216
+7% +$105K
MFC icon
244
Manulife Financial
MFC
$73.5B
$1.75M 0.07%
+56,154
New +$1.7M
ATEC icon
245
Alphatec Holdings
ATEC
$1.44B
$1.74M 0.07%
171,620
+48,315
+39% +$519K
GSK icon
246
GSK
GSK
$106B
$1.74M 0.07%
44,879
-635
-1% -$23.2K
NRG icon
247
NRG Energy
NRG
$24.8B
$1.73M 0.07%
18,149
-1,043
-5% -$105K
EEM icon
248
iShares MSCI Emerging Markets ETF
EEM
$29.5B
$1.7M 0.07%
39,000
– –
HRB icon
249
H&R Block
HRB
$5.86B
$1.68M 0.07%
30,650
-1,432
-4% -$76.5K
SBUX icon
250
Starbucks
SBUX
$120B
$1.68M 0.07%
17,123
+439
+3% +$45.4K
8 9
10
11 12

Similar funds

TCM
Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return
HA
Heartland Advisors Milwaukee, Wisconsin $1.96B AUM 28.26% 1-Year Est. Return
NIM
Needham Investment Management New York $1.96B AUM 101.23% 1-Year Est. Return
RMCM
Reynders McVeigh Capital Management Boston, Massachusetts $1.98B AUM 23.37% 1-Year Est. Return
FC
Finepoint Capital Boston, Massachusetts $1.95B AUM 45.61% 1-Year Est. Return
SC
Syon Capital San Francisco, California $1.99B AUM 22.67% 1-Year Est. Return
CAM
Cormorant Asset Management Boston, Massachusetts $1.99B AUM 737.95% 1-Year Est. Return
BC
Blackhill Capital Morristown, New Jersey $1.94B AUM 18.09% 1-Year Est. Return

F/M Investments's Q1 2025 Portfolio in Review

As of Q1 2025, F/M Investments held 422 positions worth $2.51B, down 7.4% from $2.71B the previous quarter. Its ten largest holdings account for 32% of the portfolio.

F/M Investments withdrew a net $78.6M in Q1 2025, closing 31 positions and reducing 193 holdings. Its most notable exit was Intra-Cellular Therapies Inc., an estimated $3.08M position sold in full.

By sector, the portfolio is most concentrated in Technology at 22% of assets, down from 24% a quarter earlier, followed by Healthcare and Financials.

Against the trend, F/M Investments opened a new position in Idexx Laboratories worth $11.4M.

  • F/M Investments's largest Q1 2025 buy was Idexx Laboratories: 27,178 shares worth $11.4M.
  • F/M Investments added most to Palantir in Q1 2025, an estimated $3.23M increase.
  • F/M Investments's biggest Q1 2025 reduction was UnitedHealth, cutting an estimated $18.7M.
  • F/M Investments fully exited Intra-Cellular Therapies Inc. in Q1 2025, selling an estimated $3.08M.
  • F/M Investments's ten largest holdings make up 32% of its $2.51B portfolio in Q1 2025.
  • F/M Investments opened 23 new positions and closed 31 in Q1 2025.
  • F/M Investments's portfolio value fell 7.4% quarter-over-quarter to $2.51B.

Based on F/M Investments's 13F filing for Q1 2025, filed 14 May 2025.